Search

Frederick D. Bailey

Examiner (ID: 6138)

Most Active Art Unit
2483
Art Unit(s)
2483
Total Applications
547
Issued Applications
372
Pending Applications
0
Abandoned Applications
179

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 10851055 [patent_doc_number] => 08877736 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-04 [patent_title] => 'Method for treating keloid by administering 3′sialyllactose or 6′sialyllactose as a pharmaceutical or cosmetic' [patent_app_type] => utility [patent_app_number] => 13/376463 [patent_app_country] => US [patent_app_date] => 2010-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3786 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13376463 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/376463
Method for treating keloid by administering 3′sialyllactose or 6′sialyllactose as a pharmaceutical or cosmetic Apr 8, 2010 Issued
Array ( [id] => 9749787 [patent_doc_number] => 08841262 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-23 [patent_title] => 'Agent for inhibiting peritoneal membrane thickening' [patent_app_type] => utility [patent_app_number] => 13/259558 [patent_app_country] => US [patent_app_date] => 2010-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 8788 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13259558 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/259558
Agent for inhibiting peritoneal membrane thickening Mar 29, 2010 Issued
Array ( [id] => 10070920 [patent_doc_number] => 09109266 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-18 [patent_title] => 'Process of producing sugar composition comprising D-psicose and D-allose via strong alkaline isomerization of D-glucose/D-fructose or alkaline pre-treatment of D-glucose/D-fructose followed by isomerization in the presence of a basic ion exchange resin' [patent_app_type] => utility [patent_app_number] => 13/262558 [patent_app_country] => US [patent_app_date] => 2010-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 18906 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13262558 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/262558
Process of producing sugar composition comprising D-psicose and D-allose via strong alkaline isomerization of D-glucose/D-fructose or alkaline pre-treatment of D-glucose/D-fructose followed by isomerization in the presence of a basic ion exchange resin Mar 25, 2010 Issued
Array ( [id] => 10062820 [patent_doc_number] => 09101648 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-11 [patent_title] => 'Pharmaceutical composition comprising mannooligosaccharides derived from coffee for treatment of lifestyle-related disease, and food useful for treatment of lifestyle-related disease' [patent_app_type] => utility [patent_app_number] => 13/260405 [patent_app_country] => US [patent_app_date] => 2010-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 4854 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13260405 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/260405
Pharmaceutical composition comprising mannooligosaccharides derived from coffee for treatment of lifestyle-related disease, and food useful for treatment of lifestyle-related disease Mar 23, 2010 Issued
Array ( [id] => 8095979 [patent_doc_number] => 20120083599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-05 [patent_title] => 'Biomolecular Labelling Using Multifunctional Biotin Analogues' [patent_app_type] => utility [patent_app_number] => 13/257562 [patent_app_country] => US [patent_app_date] => 2010-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16761 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20120083599.pdf [firstpage_image] =>[orig_patent_app_number] => 13257562 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/257562
Biomolecular Labelling Using Multifunctional Biotin Analogues Mar 21, 2010 Abandoned
Array ( [id] => 9817920 [patent_doc_number] => 08927706 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-06 [patent_title] => 'Based-assisted formation of tin-sucrose adducts' [patent_app_type] => utility [patent_app_number] => 13/262102 [patent_app_country] => US [patent_app_date] => 2010-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6312 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13262102 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/262102
Based-assisted formation of tin-sucrose adducts Mar 9, 2010 Issued
Array ( [id] => 8173600 [patent_doc_number] => 20120108532 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'PHARMACEUTICAL COMPOSITION FOR NEUROPROTECTIVE TREATMENT IN PATIENTS WITH ICTUS COMPRISING CITICOLINE AND URIC ACID' [patent_app_type] => utility [patent_app_number] => 13/262586 [patent_app_country] => US [patent_app_date] => 2010-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2703 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20120108532.pdf [firstpage_image] =>[orig_patent_app_number] => 13262586 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/262586
PHARMACEUTICAL COMPOSITION FOR NEUROPROTECTIVE TREATMENT IN PATIENTS WITH ICTUS COMPRISING CITICOLINE AND URIC ACID Feb 28, 2010 Abandoned
Array ( [id] => 8056049 [patent_doc_number] => 20120077760 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'NOVEL SALTS OF SITAGLIPTIN' [patent_app_type] => utility [patent_app_number] => 13/148451 [patent_app_country] => US [patent_app_date] => 2010-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7040 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20120077760.pdf [firstpage_image] =>[orig_patent_app_number] => 13148451 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/148451
NOVEL SALTS OF SITAGLIPTIN Feb 9, 2010 Abandoned
Array ( [id] => 7757442 [patent_doc_number] => 20120029179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'PROCESS FOR THE SYNTHESIS OF CLEISTANTHIN' [patent_app_type] => utility [patent_app_number] => 13/147970 [patent_app_country] => US [patent_app_date] => 2010-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5877 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20120029179.pdf [firstpage_image] =>[orig_patent_app_number] => 13147970 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/147970
PROCESS FOR THE SYNTHESIS OF CLEISTANTHIN Feb 3, 2010 Abandoned
Array ( [id] => 9831891 [patent_doc_number] => 08940705 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-27 [patent_title] => 'Method of treating disease and selectively modulating transcriptional regulation by a glucocorticoid receptor by administering aclacinomycin and dexamethasone' [patent_app_type] => utility [patent_app_number] => 13/143727 [patent_app_country] => US [patent_app_date] => 2010-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7619 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13143727 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/143727
Method of treating disease and selectively modulating transcriptional regulation by a glucocorticoid receptor by administering aclacinomycin and dexamethasone Jan 7, 2010 Issued
Array ( [id] => 8671404 [patent_doc_number] => 20130045942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-21 [patent_title] => 'N6-SUBSTITUTED ADENOSINE DERIVATIVES AND N6-SUBSTITUTED ADENINE DERIVATIVES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/515152 [patent_app_country] => US [patent_app_date] => 2009-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 82740 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13515152 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/515152
N Dec 9, 2009 Issued
Array ( [id] => 6018145 [patent_doc_number] => 20110224724 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'HYDROGEL TISSUE ADHESIVE FORMED FROM AMINATED POLYSACCHARIDE AND ALDEHYDE-FUNCTIONALIZED MULTI-ARM POLYETHER' [patent_app_type] => utility [patent_app_number] => 13/129617 [patent_app_country] => US [patent_app_date] => 2009-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12178 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20110224724.pdf [firstpage_image] =>[orig_patent_app_number] => 13129617 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/129617
Hydrogel tissue adhesive formed from aminated polysaccharide and aldehyde-functionalized multi-arm polyether Aug 30, 2009 Issued
Array ( [id] => 7511676 [patent_doc_number] => 20110257386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'ISOLATION OF NUCLEIC ACID' [patent_app_type] => utility [patent_app_number] => 13/057947 [patent_app_country] => US [patent_app_date] => 2009-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5176 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20110257386.pdf [firstpage_image] =>[orig_patent_app_number] => 13057947 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/057947
Isolation of nucleic acid Aug 6, 2009 Issued
Array ( [id] => 5557840 [patent_doc_number] => 20090269417 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'THIOLATED CHITOSAN GEL' [patent_app_type] => utility [patent_app_number] => 12/429135 [patent_app_country] => US [patent_app_date] => 2009-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5984 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20090269417.pdf [firstpage_image] =>[orig_patent_app_number] => 12429135 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/429135
THIOLATED CHITOSAN GEL Apr 22, 2009 Abandoned
Array ( [id] => 11204192 [patent_doc_number] => 09433805 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-06 [patent_title] => 'Method for dermal regeneration by administering an ether cross-linked glucomannan/hyaluronic acid composition' [patent_app_type] => utility [patent_app_number] => 12/681391 [patent_app_country] => US [patent_app_date] => 2008-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 16 [patent_no_of_words] => 13639 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 185 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12681391 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/681391
Method for dermal regeneration by administering an ether cross-linked glucomannan/hyaluronic acid composition Oct 2, 2008 Issued
Array ( [id] => 7733348 [patent_doc_number] => 20120015902 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'ARABINOXYLO-OLIGOSACCHARIDES USEFUL AGAINST GASTROINTESTINAL INFECTIONS' [patent_app_type] => utility [patent_app_number] => 12/680435 [patent_app_country] => US [patent_app_date] => 2008-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7374 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20120015902.pdf [firstpage_image] =>[orig_patent_app_number] => 12680435 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/680435
Arabinoxylo-oligosaccharides useful against gastrointestinal infections Sep 28, 2008 Issued
Array ( [id] => 7567979 [patent_doc_number] => 20110288042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'STABLE HIGHLY PURE AZACITIDINE AND PREPARATION METHODS THEREFOR' [patent_app_type] => utility [patent_app_number] => 12/671663 [patent_app_country] => US [patent_app_date] => 2008-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7608 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20110288042.pdf [firstpage_image] =>[orig_patent_app_number] => 12671663 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/671663
STABLE HIGHLY PURE AZACITIDINE AND PREPARATION METHODS THEREFOR Jul 22, 2008 Abandoned
Array ( [id] => 6639713 [patent_doc_number] => 20100174059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'PROCESS FOR THE PRODUCTION OF NUCLEOTIDE SUGARS' [patent_app_type] => utility [patent_app_number] => 12/663748 [patent_app_country] => US [patent_app_date] => 2008-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 31523 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0174/20100174059.pdf [firstpage_image] =>[orig_patent_app_number] => 12663748 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/663748
Process for the production of purified cytidinemonophosphate-sialic acid-polyalkylene oxide (CMP-SA-PEG) as modified nucleotide sugars via anion exchange chromatography Jun 11, 2008 Issued
Array ( [id] => 6366180 [patent_doc_number] => 20100314322 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'PURIFICATION PROCEDURE FOR THE PREPARATION OF THE RADIOACTIVE TRACER 3\'-DEOXY-3\'- [18F] LUOROTHYMIDINE ([18F] FLT)' [patent_app_type] => utility [patent_app_number] => 12/602410 [patent_app_country] => US [patent_app_date] => 2008-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3059 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0314/20100314322.pdf [firstpage_image] =>[orig_patent_app_number] => 12602410 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/602410
Purification procedure for the preparation of the radioactive tracer 3′-deoxy-3′-[18F] fluorothymidine ([18F]FLT) Apr 21, 2008 Issued
Array ( [id] => 5938030 [patent_doc_number] => 20110213137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'ISOTOPICALLY-LABELED GLYCANS' [patent_app_type] => utility [patent_app_number] => 12/595888 [patent_app_country] => US [patent_app_date] => 2008-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 23345 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20110213137.pdf [firstpage_image] =>[orig_patent_app_number] => 12595888 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/595888
ISOTOPICALLY-LABELED GLYCANS Apr 14, 2008 Abandoned
Menu